ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,977Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 231

$858K Total Retail Price of All Prescriptions

Rank: 5 out of 231

438 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 438 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 438 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 13,578 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
WARFARIN SODIUM 630 569 1 17
OMEPRAZOLE 533 500 2 5
FUROSEMIDE 485 473 3 6
SIMVASTATIN 452 409 4 2
MIRTAZAPINE 413 382 5 25
SERTRALINE HCL 366 361 6 18
LISINOPRIL 365 353 7 1
AMLODIPINE BESYLATE 352 338 8 4
LEVOTHYROXINE SODIUM 349 297 9 3
INSULIN SYRINGE 288 284 10 43
METOPROLOL TARTRATE 266 238 11 12
CARVEDILOL 235 227 12 24
DONEPEZIL HCL 230 221 13 26
QUETIAPINE FUMARATE 197 196 14 39
ALBUTEROL SULFATE 178 134 15 66
LANTUS 176 166 16 42
TRAMADOL HCL 164 159 17 16
GABAPENTIN 162 145 18 15
METOPROLOL SUCCINATE 148 139 19 13
TRAZODONE HCL 141 131 20 35
POLYETHYLENE GLYCOL 3350 137 128 21 36
RISPERIDONE 136 136 22 34
HYDROCHLOROTHIAZIDE 130 110 23 9
POTASSIUM CHLORIDE 127 120 24 33
CYMBALTA 124 118 25 46
HYDRALAZINE HCL 119 105 26 82
TAMSULOSIN HCL 110 110 27 30
LIDODERM 105 102 28 78
CIPROFLOXACIN HCL 102 95 29 58
ESCITALOPRAM OXALATE 101 86 30 55
NAMENDA 100 100 31 47
NOVOLOG 99 92 32 72
ATORVASTATIN CALCIUM 99 89 32 8
ZOLPIDEM TARTRATE 97 78 34 14
FENTANYL 96 90 S2 35 69
ADVAIR DISKUS 96 92 35 50
RANITIDINE HCL 95 84 37 51
METFORMIN HCL 95 91 37 7
ALENDRONATE SODIUM 92 79 39 45
OXYCODONE-ACETAMINOPHEN 90 58 S2 40 52
NYSTATIN 90 71 40 87
CLOPIDOGREL 89 84 42 44
HYDROCODONE-ACETAMINOPHEN 89 77 S3 42 21
CARBIDOPA-LEVODOPA 88 86 44 73
SYNTHROID 85 85 45 28
DIOVAN 84 84 46 27
ATENOLOL 83 76 47 11
LACTULOSE 82 82 48 84
AMIODARONE HCL 78 78 49 108
CLONIDINE HCL 77 59 50 63
LOSARTAN POTASSIUM 76 74 51 29
LEVOFLOXACIN 76 67 51 64
PRAVASTATIN SODIUM 75 72 53 10
OLANZAPINE 75 70 53 65
TRAVATAN Z 71 71 55 118
LEVETIRACETAM 70 47 56 57
PAROXETINE HCL 69 42 57 70
SEROQUEL 68 67 58 83
SPIRIVA 68 68 58 61
MUPIROCIN 67 61 60 127
ISOSORBIDE MONONITRATE ER 66 64 61 56
PROCRIT 65 65 62 199
PLAVIX 64 60 63 60
NITROFURANTOIN MONO-MACRO 62 58 64 76
GLIPIZIDE 62 47 64 71
METOCLOPRAMIDE HCL 62 22 64 103
NAPROXEN 62 53 64 114
CEPHALEXIN 62 56 64 100
PREDNISONE 61 61 69 41
GLIMEPIRIDE 60 60 70 38
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 49 71 77
JANUVIA 56 56 72 93
DIGOXIN 55 55 73 80
AZITHROMYCIN 54 48 74 32
BRIMONIDINE TARTRATE 54 54 74 166
DRONABINOL 53 53 76 225
BUPROPION HCL SR 53 52 76 225
FAMOTIDINE 52 52 78 148
BUDESONIDE 50 50 79 176
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 26, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.